RETRACTION: miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells (Retraction of Vol 17, art no 36, 2017)

被引：1
|
作者：
Hu, Yang
Xie, Hong
Liu, Yankun
Liu, Weiying
Liu, Min
Tang, Hua [1 ]
机构：
[1] Tianjin Med Univ, Tianjin Life Sci Res Ctr, 22 Qi Xiang Tai Rd, Tianjin 300070, Peoples R China
来源：
CANCER CELL INTERNATIONAL | 2021年 / 21卷 / 01期
关键词：
D O I：
10.1186/s12935-021-01958-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12935-021-01958-0
引用
收藏
页数：1
相关论文
共 50 条
  • [1] miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells (vol 17, 36, 2017)
    Hu, Yang
    Xie, Hong
    Liu, Yankun
    Liu, Weiying
    Liu, Min
    Tang, Hua
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [2] Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells
    Yang Hu
    Hong Xie
    Yankun Liu
    Weiying Liu
    Min Liu
    Hua Tang
    Cancer Cell International, 21
  • [3] RETRACTED: miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells (Retracted Article)
    Hu, Yang
    Xie, Hong
    Liu, Yankun
    Liu, Weiying
    Liu, Min
    Tang, Hua
    CANCER CELL INTERNATIONAL, 2017, 17
  • [4] RETRACTED ARTICLE: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells
    Yang Hu
    Hong Xie
    Yankun Liu
    Weiying Liu
    Min Liu
    Hua Tang
    Cancer Cell International, 17
  • [5] Correction to: RETRACTED ARTICLE: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells
    Yang Hu
    Hong Xie
    Yankun Liu
    Weiying Liu
    Min Liu
    Hua Tang
    Cancer Cell International, 20
  • [6] RETRACTION: LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by targeting miR-484 in human lung cancer cells (Retraction of Vol 119, Pg 4447, 2018)
    Zhang, Qianqian
    Li, Xiaoliang
    Li, Xiao
    Li, Xiaosu
    Chen, Zhuochang
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 (05) : 600 - 600
  • [7] miR-194 suppresses epithelial-mesenchymal transition of retinal pigment epithelial cells by directly targeting ZEB1
    Cui, Lian
    Lyu, Yali
    Jin, Xiaoliang
    Wang, Yueye
    Li, Xiang
    Wang, Juan
    Zhang, Jieping
    Deng, Zhongzhu
    Yang, Nan
    Zheng, Zixuan
    Guo, Yizheng
    Wang, Chao
    Mao, Rui
    Xu, Jingying
    Gao, Furong
    Jin, Caixia
    Zhang, Jingfa
    Tian, Haibin
    Xu, Guo-Tong
    Lu, Lixia
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (23)
  • [8] RETRACTION: Retraction Note: HOXD9 promotes epithelial-mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma
    Lv, Xiupeng
    Li, Linlin
    Lv, Li
    Qu, Xiaotong
    Jin, Shi
    Li, Kejun
    Deng, Xiaoqin
    Cheng, Lei
    He, Hui
    Dong, Lei
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [9] RETRACTION: miR-4429 Regulates the Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Cervical Cancer by Targeting FOXM1 (Retraction of Vol 12, Pg 5301, 2020)
    Liang, L.
    Zheng, Y. W.
    Wang, Y. L.
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 1009 - 1009
  • [10] miR-1271 inhibits growth, invasion and epithelial-mesenchymal transition by targeting ZEB1 in ovarian cancer cells
    Jiao, Yanni
    Zhu, Guiping
    Yu, Jiang
    Li, Ying
    Wu, Man
    Zhao, Jing
    Tian, Xiangwen
    ONCOTARGETS AND THERAPY, 2019, 12 : 6973 - 6980
12345